Table 3.
Antibody response and titres among patients with cancer and controls.
Patients with cancer (N = 93) | Controls (N = 186) | p-value | |
---|---|---|---|
RBD-IgG positive N (%) | 78 (83.9) | 179 (96.3) | 0.0001 |
RBD-IgG titre GMT (95%CI) | 2.3 (2.0–2.7) | 3.2 (3.0–3.4) | 0.0002 |
Neutralising Ab titre GMT (95%CI) | 96.7 (71.3–131.2) | 87.5 (74.6–102.7) | 0.566 |
RBD, receptor-binding domain; IgG, immunoglobin G; CI, confidence interval; Ab, antibody; GMT, geometric mean.